(Q34452119)

English

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

0 references

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose (English)

1 reference

Europe PubMed Central

2 August 2017

Kawasaki disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Terai M

1

1 reference

Europe PubMed Central

2 August 2017

Shulman ST

2

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 December 1997

1 reference

Europe PubMed Central

2 August 2017

The Journal of Pediatrics

1 reference

Europe PubMed Central

2 August 2017

131

1 reference

Europe PubMed Central

2 August 2017

888-893

1 reference

Europe PubMed Central

2 August 2017

6

1 reference

Europe PubMed Central

2 August 2017

Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970038-6

7 January 2021

High-dose intravenous gammaglobulin for Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970038-6

7 January 2021

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970038-6

7 January 2021

High-dose gammaglobulin therapy for Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970038-6

7 January 2021

Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970038-6

7 January 2021

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970038-6

7 January 2021

Intravenous γ-Globulin Treatment in Kawasaki Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970038-6

7 January 2021

Iv gamma globulin treatment of Kawasaki disease in Japan: results of a nationwide survey

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970038-6

7 January 2021

Diagnosis and therapy of Kawasaki disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970038-6

7 January 2021

Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2897%2970038-6

7 January 2021

Identifiers

10.1016/S0022-3476(97)70038-6

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34452119&oldid=1572578382"